Currently available contraceptive methods are not meeting many women's needs. As many as four in 10 women are not satisfied with their current method, reporting difficulty of use, problems with side effects, worry about effectiveness and reduced sexual pleasure. The large gap between typical- and perfect-use failure rates indicates widespread inconsistent use of the most common contraceptive methods. Only three pill users per 1,000 would become pregnant in a year if using the method perfectly, but in the United States, 90 in 1,000 actually become pregnant; for male condoms, the pregnancy rate is 20 in 1,000 when use is consistent and correct, but more than 180 in 1,000 with typical use. Unintended pregnancy rates are also driven by women who forgo contraceptives entirely. One in 12 U.S. women seeking to avoid pregnancy do not use any method of contraception, and another one in six have gaps in use. Frequent contraceptive discontinuation contributes to the high rates of unintended pregnancy and abortion in the United States.[4, 5]
Low levels of effective contraceptive use and high levels of dissatisfaction may be due to barriers to contraceptive availability or to a mismatch between women's preferences and the features of available methods. Research on -inconsistent contraceptive use has cited barriers to access and dissatisfaction with method characteristics as primary reasons that women experience gaps in coverage. All highly effective methods require a prescription from a physician or nurse practitioner. The cost of initiating use of a prescription method, the cost of resupply visits and the need for return visits to a clinic or pharmacy may deter women from effective, ongoing contraceptive use.[6-10] Changes in prescription requirements can improve contraceptive access. The over-the-counter availability of emergency contraception for women aged 17 and older has reenergized the call to make regular oral contraceptives available without a prescription. Progestin-only oral contraceptives, which contain the same class of hormone found in emergency contraception, are thought to be a better prospect for a shift to over-the-counter status than combined pills, because they have fewer contraindications.
Recent advances in contraceptive technology have increased women's options and have the potential to improve how well contraceptive features match women's preferences. Since 2001, women in the United States have seen the introduction of new modes of delivery of hormonal contraceptives—a patch, a vaginal ring, a -single-rod subdermal implant and a levonogestrel--releasing IUD. Advances have also been made in the -availability of nonhormonal methods—an improved female condom and one-size-fits-most diaphragms. In addition, efforts are under way to make existing contraceptives easier to use; methods under development include self-administered injectables, a vaginal ring that can be used for up to a year and a pill that needs to be taken only when a woman has sex.
A few studies have examined what contraceptive method features are most and least appealing to potential users. Sable and colleagues looked at 54 attitudes about birth control among women in Missouri seeking pregnancy tests, while Unger and Molina examined attitudes that can act as barriers to contraceptive use among Latinas in Los Angeles. These two studies, which focused on women's negative experiences in initiating or sustaining use,1 are important for understanding women's history of contraceptive use, but they do not indicate what features women would look for in future methods. Grady and colleagues assessed the importance to both women and men aged 20–27 of seven contraceptive features: The method is effective, protects one's partner from STDs, protects oneself from STDs, is safe, is easy to use, does not interfere with sexual pleasure and does not require planning. They found that women and men ranked these in the same order of importance (as listed), except that women valued no planning over lack of interference with sexual pleasure. The study, which was based on two national surveys, did not ask about other features of birth control or draw conclusions about what methods might be best aligned with most users’ preferences.
We report here women's preferences for the features of contraceptive methods and how these preferences are satisfied by current methods and possible future ones. We focus on a population at particularly high risk for unintended pregnancy—women seeking abortion services. Such women are fecund, the vast majority do not want to become pregnant soon, and they are likely to have unprotected sex in the future or to use contraceptives inconsistently.[24, 25]
- Top of page
Sixty-one percent of the 983 eligible women who presented at the clinics agreed to participate in the survey. Of these, 574 (95%) responded to questions about preferred contraceptive features and made up our analytic sample. Most of those who skipped these questions did so because they stopped the survey prematurely.
Fifty-four percent of respondents were in their 20s, 17% were younger than 20, and 22% were 30 or older; 7% were missing data (Table 2). Forty-five percent of the women were black, 25% were white, 11% were Hispanic and 19% gave another response or did not answer the question. Three-quarters of women were seeking a first-trimester abortion. Seventy-six percent had had intercourse at least weekly in the three months prior to conception, and 89% had not consistently used a method. About one-quarter of respondents reported that they had never used a contraceptive method in the three months prior to conception. On the basis of the responses to the questions on frequency of intercourse and contraceptive use, we estimate that three-quarters of the respondents had had unprotected intercourse three or more times in the three months leading to conception (not shown). Many women expected to have unprotected intercourse in the next three months: Six percent said it was extremely likely, and 16% said it was somewhat likely. However, 87% reported that they planned to use contraceptives after the abortion (not shown).
Table 2. Percentage distribution of study participants, by selected characteristics
|Frequency of intercourse in the|
|three months prior to conception|
|Once or twice||5|
|% of acts in which a contraceptive was|
|used in the three months prior to conception|
|Likelihood of unprotected sex in the next three months|
|Not at all likely||75|
|Prefer not to answer||3|
The three features that were extremely important for the largest proportions of women were effectiveness (84%), lack of side effects (78%) and affordability (76%—Table 3, page 198). More than two-thirds of respondents chose the four next most commonly preferred features: The method is easy to get (74%) and to use (74%), and the woman has control over its use (70%) and responsibility for its use (69%).
Table 3. Percentage distribution of women, by opinions of importance of selected contraceptive features
|Feature||Extremely important||Somewhat important||Not at all important||No answer||Total|
|Few/no side effects||78||16||3||2||100|
|Easy to get||74||17||4||5||100|
|Easy to use||74||18||3||6||100|
|Woman controls when and whether to use||70||19||6||4||100|
|Woman, and not her partner,|
|is responsible for use||69||21||6||4||100|
|Not used at time of sex||65||19||8||7||100|
|Does not reduce woman's sexual enjoyment||64||21||9||5||100|
|Does not reduce partner's sexual enjoyment||61||22||11||6||100|
|Protects against STDs||61||20||13||6||100|
|Use is undetectable||57||18||19||6||100|
|Has a health benefit||56||25||13||7||100|
|Does not change menstrual period||51||27||17||6||100|
|Can be stopped at any time||50||29||12||9||100|
|Pregnancy possible immediately after use ends|
|No doctor/clinic visit needed||42||24||25||9||100|
|Used only at time of sex||35||18||35||12||100|
On average, women identified 10.6 of the 18 characteristics as being “extremely important.” Women who said they were likely to have unprotected intercourse in the next three months identified 9.7 features as extremely important, whereas those who were not likely to have unprotected sex identified 10.8 (Table 4, page 198). Women who anticipated having unprotected sex were significantly less likely than others to consider seven features (effectiveness, lack of side effects, affordability, accessibility, ease of use, not used at time of sex and no reduction in partners’ enjoyment) extremely important. Black women had a different profile of contraceptive preferences than white women. They identified an average of 11.0 features as extremely important, whereas white women identified 9.7. Black women were less likely than white women to say that effectiveness or sexual enjoyment is important, but they were more likely to care about features relating to control, health effects, timing relative to intercourse and protection against STDs. Teenagers reported an average of 9.7 extremely important features and were less likely than adults to report that affordability, accessibility and their partner's sexual enjoyment are important.
Table 4. Mean number of contraceptive features that are extremely important to women, and percentage of women who consider each feature extremely important, by selected characteristics of women
|Feature||Likely to haveunprotected sex||Race||Age|
|No. of features that are extremely important||10.8||9.7*||9.7||11.0*||10.6||9.7|
|Few/no side effects||81||70*||76||81||79||77|
|Easy to get||80||63*||74||78||77||62*|
|Easy to use||78||63*||72||75||75||66|
|Woman controls when and whether to use||73||68||65||74*||71||65|
|Woman, and not her partner, is responsible for use||71||66||64||76*||70||63|
|Not used at time of sex||68||56*||60||73*||67||58|
|Does not reduce woman's sexual enjoyment||67||58||72||60*||65||56|
|Does not reduce partner's sexual enjoyment||64||54*||70||57*||63||49*|
|Protects against STDs||63||57||45||68*||60||65|
|Use is undetectable||56||63||57||58||56||62|
|Has a health benefit||59||51||50||62*||57||54|
|Does not change menstrual periods||52||52||40||55*||52||44|
|Can be stopped at any time||53||44||40||56*||51||43|
|Pregnancy possible immediately after use ends||51||48||39||55*||50||47|
|No doctor/clinic visit needed||43||45||37||45||43||36|
|Used only at time of sex||35||39||18||45*||35||37|
For 91% of women, no contraceptive method has all the features they think are extremely important. The dearth of perfect matches is due largely to conflicts between preferences. For example, 73% of women want a method that is very effective and has few or no side effects; according to our assessments (Table 1), that combination does not exist, although an individual woman may find an effective method that does not have significant side effects for her. Some of the failure to match with a contraceptive method is due to possible inconsistencies in women's preferences; 29% of women want a method that is used only when intercourse is anticipated and that does not have to be remembered with each act, a combination that is difficult to achieve.
The average percentage match for currently available methods ranged from 67%, for the ring and sponge, to 37%, for withdrawal and natural family planning (Table 5, page 199). For oral contraceptives, the most common reversible method of contraception, it was 60%; for male condoms, 42%.
Table 5. Percentage of extremely important features possessed by current and potential new methods of contraception, and percentage of women for whom each method is a perfect match or a good match
|Contraceptive method||% of extremelyimportantfeatures||% of women|
|Perfect match||Good match|
|Currently available methods|
|Withdrawal/natural family planning|
|Potential new methods|
|Over-the-counter pericoital pill||68||3||27|
Some new methods in development and new modes of delivery for existing methods have the potential to satisfy a substantial proportion of women's preferences. If oral contraceptives were available without a prescription, they would have 71% of extremely important features. A pericoital pill would have 64% of women's desired features, or 68% if it were available without a prescription. A self-removable IUD would have 61% of women's desired features, while a diaphragm that could be purchased over the counter at a drugstore would have 60% of women's extremely important features.
Few women will be able to find contraceptive methods that have all the features that are extremely important to them. No method is a perfect match for more than 4% of women (the proportion for emergency contraception and an over-the-counter oral contraceptive); most contain all the important features for about 1–2%. However, good matches—methods that have three-quarters or more of a woman's extremely important features—are more common. The ring is a good match for nearly one-third of women; the sponge and emergency contraception, for about one-quarter. An over-the-counter oral contraceptive would be a good match for the most women (41%); about one-quarter of women would have a good match with an over-the-counter pericoital pill.
The estimated percentage match did not predict which method a woman intended to use after her abortion or how consistently she intended to use it. Women intending to use condoms, oral contraceptives, the ring and the injectable did not have significantly higher percentage matches for those methods than women who were not planning to use them. However, women choosing an IUD had a slightly higher match for the IUD than women who did not choose one (59% vs. 55%; p<.05). Also, low percentage match with specific intended future contraceptive methods was not associated with women's reported willingness to have unprotected intercourse in the near future.
Our results are sensitive to our assumption that women experience side effects from hormonal methods of contraception. When we included “the method has few or no side effects” as a feature of hormonal methods, the percentage of extremely important features matched by each hormonal method increased by 8.4 percentage points. This change elevated the patch and oral contraceptives above the sponge and emergency contraception in the ranking of greatest percentage match.
- Top of page
Asking women about the features they would like to see in a contraceptive method may give us a better understanding of their preferences than asking their opinions of existing methods or about their experiences with contraception. Opinions about specific methods may be limited by contraceptive knowledge and misconceptions, while discussion of past method use may reveal dissatisfaction, but not factors associated with current intentions.
Not surprisingly, contraceptive effectiveness and a lack of side effects were the most commonly preferred features among our sample. Women want contraceptives that reliably prevent pregnancy and do so without introducing unwanted physiological responses. Additionally, they want their method to be easy to use, and would prefer not to have to use it with each act of intercourse. Further, women want the method to be affordable and easy to get, and they want control over whether and when to use it.
We found a large gap between the contraceptive features women want and the features of currently available methods. Improvements in access and new contraceptive technologies may narrow this gap. For example, an over-the-counter oral contraceptive is a closer match with women's preferences than the prescription-only product. A pericoital contraceptive pill may be a good match for women whose needs are not currently being met.
Inconsistent contraceptive use is likely due to both poor access and method dissatisfaction. The large number of reported features that women consider extremely important indicates that strong feelings and complex considerations go into selecting a contraceptive method. Women would likely be more satisfied if they had access to a method that was aligned with their preferences; this in turn, may lead to more consistent use.
One limitation of our methodology is that contraceptives that had more of the features we asked about were relatively advantaged in the match score. For example, we asked women whether they wanted a method that is easy to get and also a method they could get without going to a clinic. A nonprescription method could match both of these items, whereas a prescription method would match neither. We did not choose features in an effort to assign an equal number of features for each contraceptive method—realistically, not all contraceptives have the same number of positive attributes. However, our emphasis on access rather than, say, clinical action or desired duration of use influenced the percentage match. Our analysis is further limited because we lacked information on the relative importance of each method feature to each woman, and many women listed multiple features as “extremely important.” Further discussions of method features may benefit from such inquiry.